Expression and Biological Evaluation of an Engineered Recombinant L-asparaginase Designed by In Silico Method Based on Sequence of the Enzyme from Escherichia coli

Mahrokh Dastmalchi ^1,2 , Mahdiyeh Alizadeh ^3,4 , Omid Jamshidi-Kandjan ^3,5, Hassan Rezazadeh ⁴, Maryam Hamzeh-Mivehroud ^3,4, Mohammad M Farajollahi ¹, Siavoush Dastmalchi ^3,4,6 *

Cited by CrossRef: 2

1- Shishparenok A, Gladilina Y, Zhdanov D. Engineering and Expression Strategies for Optimization of L-Asparaginase Development and Production. IJMS. 2023;24(20):15220 [Crossref]

2- Dastmalchi M, Hamzeh-Mivehroud M, Rezazadeh H, Farajollahi M, Dastmalchi S. Investigating Functional and Folding Stability of an Engineered E. coli L-asparaginase Harboring Y176F/S241C Mutations. Adv Pharm Bull. 2024;14(3):675 [Crossref]

3- Sonowal S, Pathak K, Das D, Buragohain K, Gogoi A, Borah N, Das A, Nath R. l‐Asparaginase Bio‐Betters: Insight Into Current Formulations, Optimization Strategies and Future Bioengineering Frontiers in Anti‐Cancer Drug Development. Advanced Therapeutics. 2024; [Crossref]